Skip to main content

Table 3 C-statistic for the models predicting CKD-related pharmacotherapy

From: Identifying individuals at risk of needing CKD associated medications in a European kidney disease cohort

 

Area

95% CIs

ESAs

 Derivation cohort

0.700

0.643–0.750

 Validation cohort

0.728

0.652–0.803

Iron

 Derivation cohort

0.641

0.568–0.713

 Validation cohort

0.630

0.545–0.715

Phosphate binders

 Derivation cohort

0.732

0.667–0.797

 Validation cohort

0.741

0.663–0.819

VDRA

 Derivation cohort

0.659

0.619–0.716

 Validation cohort

0.668

0.590–0.729